Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
about
Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancersThe role of systemic treatment before, during, and after definitive treatmentThe Indian scenario of head and neck oncology - Challenging the dogmasAn update on larynx cancerOptimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapyManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinomaGuidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience.Current concepts in management of oral cancer--surgery.Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV eraAssociation of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue CancersIs There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?Current Role of Surgery in the Management of Oropharyngeal CancerFalse Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers.Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue.Extracapsular tumor extension in cervical lymph nodes: reconciling the literature and seer data.Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer.A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue.Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.Free thyroid transfer: Short-term results of a novel procedure to prevent post-radiation hypothyroidismIntraoperative radiotherapy: review of techniques and results.Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.Designing biomarker studies for head and neck cancer.Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma.Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234FDG-PET staging and importance of lymph node SUV in head and neck cancer.Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence.Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase IManagement of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.Oncologic and functional outcomes of partial laryngeal surgery for intermediate-stage laryngeal cancer.Surgical margins and primary site resection in achieving local control in oral cancer resections.Traditional transcutaneous approaches in head and neck surgeryHead and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.[The development of TORS in Europe].
P2860
Q26773647-FBA6C1A6-9C5B-4B23-B045-BBC79D9D9D8AQ26859285-76CF6C87-9E8B-43D1-AB0C-38CFE44B1433Q28072546-1909AF88-5383-48FF-95D3-4F5B01EEFAB2Q28079132-F53B22EE-8F48-4A8D-AEF5-AA5974B75B40Q28083540-015743F7-D712-471E-B3AC-A8C43A664EE6Q30252081-3EAC0692-4575-4FBB-A56E-437A22638C06Q30360150-BF01D3C5-9B83-4D4D-AC3B-6982EC5E6003Q30361804-18AA7B1F-7F93-4826-B64A-53DE25FE8EC6Q31057384-258D36AA-C33E-40AF-8EA6-2E0900F43FC9Q31063952-FC4C42F0-1DD2-44A5-A153-973071170D3CQ31114002-C183B439-CDD6-40D5-8D43-198CF1869B70Q33357127-5CD81A95-BFDB-41DF-9FDC-69CAAE8B4169Q33380006-15E2E6E0-A86F-4E5F-A7F3-D4C5B465EACEQ33477468-E5CFA108-16C2-4BBF-B0B6-F4BCD9F95ED6Q33568275-C016A499-0D27-4B72-BD0C-8FD51704599AQ33585905-162D6C5A-F35F-465D-BDD4-BC639320BB20Q33652561-831E88C6-E4DC-405A-BC6B-B2C707A4B9FFQ33652572-7A95B2C5-0E7E-42D9-9D94-08EF24144239Q33658264-733E5199-F824-4C5D-9203-50467A891F30Q33682640-33AC9F6A-F600-44AD-AC67-1F6356A2B8F5Q33687512-20A37134-4662-427A-8523-E18D4A8EDDE3Q33717319-7BB34A5E-A588-462E-86C5-7F0D1D83379DQ33807703-B129FEFC-D1FC-4D8E-8D72-FFA0B4B7E387Q33809636-A6EEBE78-F9C7-481A-BD3D-D456A9260757Q33834168-92E96A17-557E-4BBA-828C-388E1E8DE4FEQ33860465-F7D724F9-E7AC-493E-8215-9249F0C26430Q33918767-F750DD05-7276-4CFC-9D38-88336868F394Q33971467-A65978BB-BB67-4C59-BBBB-77E6DC74B2F6Q33986916-D37FC355-A795-4DCC-BE95-58ADDA582586Q34000997-92A711EE-A67D-4B1C-952C-C7C50B3F42F0Q34043837-255ECDDF-842E-433F-AD40-C5A2BE5E207DQ34158132-D7916106-2D49-4676-B678-C200FF54C3FDQ34257367-F0D0288B-4620-4342-B115-6A9F33F89BCAQ34424944-61AEAB14-5855-403F-8538-71049AA238B8Q34468516-A0AF4576-60CE-4F0B-B447-3FACDD8EA704Q34477920-7452A765-C809-4C3D-8EE6-57C753BE4017Q34548122-7C56A490-977A-49B0-86F9-6D2DC1D855C1Q34561756-506D1CDF-FEFE-46D0-934D-27245DF124E5Q34595119-AF4E17DF-3BB9-4E60-9B60-D0456B45CB8EQ34641476-701B5892-2EB1-4EC5-BBA1-06116848AE47
P2860
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
description
article
@en
im Januar 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2005
@uk
ലേഖനം
@ml
name
Defining risk levels in locall ...... RTC (#22931) and RTOG (# 9501)
@en
Defining risk levels in locall ...... emotherapy trials of the EORTC
@nl
type
label
Defining risk levels in locall ...... RTC (#22931) and RTOG (# 9501)
@en
Defining risk levels in locall ...... emotherapy trials of the EORTC
@nl
prefLabel
Defining risk levels in locall ...... RTC (#22931) and RTOG (# 9501)
@en
Defining risk levels in locall ...... emotherapy trials of the EORTC
@nl
P2093
P356
P1433
P1476
Defining risk levels in locall ...... RTC (#22931) and RTOG (# 9501)
@en
P2093
Arlene Forastiere
Esat Mahmut Ozsahin
J. Bourhis
J. L. Lefèbvre
Jacques Bernier
Jay S. Cooper
John R. Jacobs
Kie-Kian Ang
M. van Glabbeke
P304
P356
10.1002/HED.20279
P577
2005-01-01T00:00:00Z